Table 2: Persistence and compliance with oral antidiabetic treatment according to level of interpersonal continuity of care.

Medication adherence construct*	Level of continuity of care; no. of patients (no.  [%] with adherence construct)
	High	Intermediate	Low
Persistence with antidiabetic treatment among the 60 924 study patients	20 305 (16 820 [82.8])	19 898 (15 886 [79.8])	20 721 (16 301 [78.7])
Compliance with antidiabetic treatment among the 49 007 patients who were persistent	16 820 (13 592 [80.8])	15 886 (12 817 [80.7])	16 301 (12 837 [78.7])

*Measured in the second year after initiation of oral antidiabetic treatment.